Recently, the FDA has questioned partial thromboplastin time (PTT) that has been run on a Cascade M-4 analyzer. The FDA has concerns about the equipment’s accuracy and sensitivity, and has indicated a preference for results from a BFT II analyzer. A backlog of PTT testing has resulted since many labs do not offer BFT II analysis.
WuXi AppTec will be an exhibitor at DeviceTalks Minnesota, June 4-5, 2018, in St. Paul, Minnesota.
DeviceTalks showcases the latest information on clinical trials, regulatory, technology and the medical device industry ecosystem.
Visit the WuXi AppTec exhibitor booth, #306, and connect with one of our many representatives. We anticipate lively discussions and fresh perspectives on the success, obstacles and future direction of the medical device industry. We also look forward to participating in the conference’s Clinical, Regulatory, Technology and Ecosystem tracks.
We are pleased to announce that Li Yang, Ph.D., DABT, has joined our team as a Senior Scientific Director in WuXi AppTec Laboratory Testing Division’s Medical Device Consulting Group.
WuXi AppTec is proud to be a sponsor at Q1 Productions’ 8th Annual Medical Device Packaging Conference, May 15-16, 2018, in Chicago, Illinois.
WuXi AppTec returns to E&L USA this May in Bethesda, MD.
PLEASE JOIN US ON THURSDAY MAY 3RD FROM 3:00 PM TO 4:30 PM FOR “THE CHANGING LANDSCAPE OF MEDTECH REGULATION,”
UNIVERSITY ENTERPRISE LABORATORIES (UEL) WITH SPEAKER DR. VANESSA HAASE, ASSOCIATE DIRECTOR OF REGULATORY TOXICOLOGY FOR WUXI APPTEC INC., ST. PAUL, MN.
Where: UEL, 1000 Westgate Drive, St. Paul, MN 55114,
1st Floor Conference Room – South Entrance